NO 1886.
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy*; D001549:Benzamides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003925:Diabetic Angiopathies / Q000188:drug therapy; D015507:Drugs, Investigational / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008071:Lipoprotein Lipase / Q000378:metabolism*; D009943:Organophosphorus Compounds / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011817:Rabbits; D051381:Rats; D013268:Stimulation, Chemical
D001549:Benzamides; D015507:Drugs, Investigational; D000960:Hypolipidemic Agents; D009943:Organophosphorus Compounds; C082137:4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide; D008071:Lipoprotein Lipase